BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34932801)

  • 1. Transcription factor GTF2B regulates AIP protein expression in growth hormone-secreting pituitary adenomas and influences tumor phenotypes.
    Cai F; Chen S; Yu X; Zhang J; Liang W; Zhang Y; Chen Y; Chen S; Hong Y; Yan W; Wang W; Zhang J; Wu Q
    Neuro Oncol; 2022 Jun; 24(6):925-935. PubMed ID: 34932801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Mutation of Aryl Hydrocarbon Receptor Interacting Protein Gene Associated with Familial Isolated Pituitary Adenoma Mediates Tumor Invasion and Growth Hormone Hypersecretion.
    Cai F; Hong Y; Xu J; Wu Q; Reis C; Yan W; Wang W; Zhang J
    World Neurosurg; 2019 Mar; 123():e45-e59. PubMed ID: 30447469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRD4 as a therapeutic target for nonfunctioning and growth hormone pituitary adenoma.
    Shi C; Ye Z; Han J; Ye X; Lu W; Ji C; Li Z; Ma Z; Zhang Q; Zhang Y; He W; Chen Z; Cao X; Shou X; Zhou X; Wang Y; Zhang Z; Li Y; Ye H; He M; Chen H; Cheng H; Sun J; Cai J; Huang C; Ye F; Luo C; Zhou B; Ding H; Zhao Y
    Neuro Oncol; 2020 Aug; 22(8):1114-1125. PubMed ID: 32246150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmented Growth Hormone Secretion and Stat3 Phosphorylation in an Aryl Hydrocarbon Receptor Interacting Protein (AIP)-Disrupted Somatotroph Cell Line.
    Fukuda T; Tanaka T; Hamaguchi Y; Kawanami T; Nomiyama T; Yanase T
    PLoS One; 2016; 11(10):e0164131. PubMed ID: 27706259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of aryl hydrocarbon receptor interacting protein (AIP) protein expression by MiR-34a in sporadic somatotropinomas.
    Dénes J; Kasuki L; Trivellin G; Colli LM; Takiya CM; Stiles CE; Barry S; de Castro M; Gadelha MR; Korbonits M
    PLoS One; 2015; 10(2):e0117107. PubMed ID: 25658813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.
    Beckers A; Aaltonen LA; Daly AF; Karhu A
    Endocr Rev; 2013 Apr; 34(2):239-77. PubMed ID: 23371967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The p300 Inhibitor A-485 Exerts Antitumor Activity in Growth Hormone Pituitary Adenoma.
    Ji C; Xu W; Ding H; Chen Z; Shi C; Han J; Yu L; Qiao N; Zhang Y; Cao X; Zhou X; Cheng H; Feng H; Luo C; Li Z; Zhou B; Ye Z; Zhao Y
    J Clin Endocrinol Metab; 2022 May; 107(6):e2291-e2300. PubMed ID: 35247260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mice with inactivation of aryl hydrocarbon receptor-interacting protein (Aip) display complete penetrance of pituitary adenomas with aberrant ARNT expression.
    Raitila A; Lehtonen HJ; Arola J; Heliövaara E; Ahlsten M; Georgitsi M; Jalanko A; Paetau A; Aaltonen LA; Karhu A
    Am J Pathol; 2010 Oct; 177(4):1969-76. PubMed ID: 20709796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive circular RNA profiling reveals that hsa_circ_0001368 is involved in growth hormone-secreting pituitary adenoma development.
    Du Q; Zhang W; Feng Q; Hao B; Cheng C; Cheng Y; Li Y; Fan X; Chen Z
    Brain Res Bull; 2020 Aug; 161():65-77. PubMed ID: 32389802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro.
    Trivellin G; Butz H; Delhove J; Igreja S; Chahal HS; Zivkovic V; McKay T; Patócs A; Grossman AB; Korbonits M
    Am J Physiol Endocrinol Metab; 2012 Sep; 303(6):E708-19. PubMed ID: 22811466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-34a is upregulated in AIP-mutated somatotropinomas and promotes octreotide resistance.
    Bogner EM; Daly AF; Gulde S; Karhu A; Irmler M; Beckers J; Mohr H; Beckers A; Pellegata NS
    Int J Cancer; 2020 Dec; 147(12):3523-3538. PubMed ID: 32856736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of EGFL7/EGFR-signaling pathway in migration and invasion of growth hormone-producing pituitary adenomas.
    Liu Q; Zhang J; Gao H; Yuan T; Kang J; Jin L; Gui S; Zhang Y
    Sci China Life Sci; 2018 Aug; 61(8):893-901. PubMed ID: 29951953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of
    Tuncer FN; Çiftçi Doğanşen S; Serbest E; Tanrıkulu S; Ekici Y; Bilgiç B; Yarman S
    Genet Test Mol Biomarkers; 2018 Dec; 22(12):702-708. PubMed ID: 30461320
    [No Abstract]   [Full Text] [Related]  

  • 14. Familial isolated pituitary adenomas (FIPA) and mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.
    Daly AF; Beckers A
    Endocrinol Metab Clin North Am; 2015 Mar; 44(1):19-25. PubMed ID: 25732638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated familial somatotropinoma: 11q13-loh and gene/protein expression analysis suggests a possible involvement of aip also in non-pituitary tumorigenesis.
    Toledo RA; Mendonca BB; Fragoso MC; Soares IC; Almeida MQ; Moraes MB; Lourenço DM; Alves VA; Bronstein MD; Toledo SP
    Clinics (Sao Paulo); 2010 Apr; 65(4):407-15. PubMed ID: 20454499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas.
    Leontiou CA; Gueorguiev M; van der Spuy J; Quinton R; Lolli F; Hassan S; Chahal HS; Igreja SC; Jordan S; Rowe J; Stolbrink M; Christian HC; Wray J; Bishop-Bailey D; Berney DM; Wass JA; Popovic V; Ribeiro-Oliveira A; Gadelha MR; Monson JP; Akker SA; Davis JR; Clayton RN; Yoshimoto K; Iwata T; Matsuno A; Eguchi K; Musat M; Flanagan D; Peters G; Bolger GB; Chapple JP; Frohman LA; Grossman AB; Korbonits M
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2390-401. PubMed ID: 18381572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-scale second-hit AIP deletion causing a pediatric growth hormone-secreting pituitary adenoma: Case report and review of literature.
    Gummadavelli A; Dinauer C; McGuone D; Vining EM; Erson-Omay EZ; Omay SB
    J Clin Neurosci; 2020 Aug; 78():420-422. PubMed ID: 32336638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of Myc-Associated Protein X (MAX) regulation in growth hormone secreting and nonfunctional pituitary adenoma.
    Tucker DW; Pangal DJ; Du R; Gogia AS; Tafreshi A; Ruzevick J; Hurth KT; Triche T; Micko A; Carpten JD; Shiroishi MS; Carmichael JD; Rhie SK; Zada G
    PLoS One; 2023; 18(4):e0284949. PubMed ID: 37104368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prkar1a haploinsufficiency ameliorates the growth hormone excess phenotype in Aip-deficient mice.
    Schernthaner-Reiter MH; Trivellin G; Roetzer T; Hainfellner JA; Starost MF; Stratakis CA
    Hum Mol Genet; 2020 Oct; 29(17):2951-2961. PubMed ID: 32821937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AIP inactivation leads to pituitary tumorigenesis through defective Gαi-cAMP signaling.
    Tuominen I; Heliövaara E; Raitila A; Rautiainen MR; Mehine M; Katainen R; Donner I; Aittomäki V; Lehtonen HJ; Ahlsten M; Kivipelto L; Schalin-Jäntti C; Arola J; Hautaniemi S; Karhu A
    Oncogene; 2015 Feb; 34(9):1174-84. PubMed ID: 24662816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.